By www.reliablemarketsize.com
Global Neurometabolic Disorders Market Size, Status And Forecast 2024-2031 Story
120
$ 3900
Neurometabolic Disorders Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Amicus Therapeutics ISU Abxis JCR Pharmaceuticals Biosidus Greenovation Biotech UAB Proforma Dong-A Socio Group ExSAR Corporation Lixte Biotechnology Neuraltus Pharmaceuticals Protalix Pharming Group Protalix BioTherapeutics Amicus Biomarin Genzyme Shire Greencross